Evidence map›Paper›PMID 41766857›Full record

ArticleFrontiers in immunology2026

Editorial: Antibody-mediated thrombotic disease.

Konstantine Halkidis, Szumam Liu, Shruti Chaturvedi

Abstract readEditorial
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Konstantine HalkidisDivision of Hematologic Malignancies and Cellular Therapeutics, Department of Internal Medicine, Institute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS, United States.
Szumam LiuDepartment of Pathology and Laboratory Medicine, Institute for Reproductive and Developmental Sciences, University of Kansas Medical Center, Kansas City, KS, United States.
Shruti ChaturvediDivision of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States.

Funding

Targeting silent cerebral infarction to improve long-term neurologic outcomes in immune thrombotic thrombocytopenic purpura (iTTP)R00HL172303 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Shruti Chaturvedi · 2024 to 2026
$1.3M
American Heart Association-American Stroke Association 933335NHLBI NIH HHS R00 HL172303
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiphospholid syndromeautoimmune diseasecomplement mediated diseasesPF4 antibodiesthrombosis

Identifiers

PMID41766857
PMCPMC12935869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.